SCHEMBL8974231

SCHEMBL8974231

COC(=O)C1(C(=O)OC)C=C(c2ccc(F)cc2)C(c2ccc(S(N)(=O)=O)nc2)=C1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA9 Q16790 10/20 0.46
CA1 P00915 9/20 0.46
CA2 P00918 9/20 0.46
CA12 O43570 8/20 0.46
CA4 P22748 3/20 0.37
CA5A P35218 3/20 0.37
CA6 P23280 2/20 0.37
CA7 P43166 2/20 0.37
CA13 Q8N1Q1 2/20 0.37
CA14 Q9ULX7 2/20 0.37
PTGS2 P35354 4/20 0.36
PTGS1 P23219 2/20 0.36
LMNA P02545 2/20 0.35
POLB P06746 1/20 0.35
MAPK1 P28482 1/20 0.35
CA5B Q9Y2D0 1/20 0.34
GPR55 Q9Y2T6 1/20 0.33
FYN P06241 1/20 0.33
KIT P10721 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8974258 0.90 PTGS2 (0.41) CA9CA1CA2CA12PTGS2
SCHEMBL8974320 0.88 CA1 (0.44) CA9CA1CA2CA12CA4
SCHEMBL8973763 0.87 POLB (0.41) CA9CA1CA2CA12POLB
SCHEMBL8974740 0.83 CA1 (0.41) CA9CA1CA2CA12CA4
SCHEMBL8974737 0.82 PTGS2 (0.51) CA9CA1CA2CA12CA4
SCHEMBL8974093 0.81 CA2 (0.44) CA9CA1CA2CA12CA4
SCHEMBL8974835 0.81 CA1 (0.44) CA9CA1CA2CA12CA4
SCHEMBL8974757 0.80 CA2 (0.41) CA9CA1CA2CA12CA4
SCHEMBL8974086 0.80 CA1 (0.42) CA9CA1CA2CA12CA4
SCHEMBL8974110 0.80 CA1 (0.39) CA9CA1CA2CA12CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5576339-A Pyridyl substituted cyclopentadienes for the treatment of inflamation HUANG HORNG-CHIH (US) 1996-11-19 US disclosed
WO-1995030656-A1 SUBSTITUTED CYCLOPENTADIENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-11-16 WO disclosed
US-5418254-A Side effect reduction G. D. SEARLE & CO. (US) 1995-05-23 US disclosed